CE Mark for Rapid Acute Kidney Injury Test Genetic Engineering News Astute Medical's NephroCheck™ test has received a CE mark for commercialization in Europe. The cartridge-based sandwich immunoassay test, run on the firm's Astute140™ Meter, quantitatively measures two validated urinary biomarkers as a risk ... Astute Medical Launches European Sales of Nephrocheck AKI Risk Assessment ... Astute Medical annonce le lancement du test NephroCheck™ |
